NO20074885L - N-proteinmutanter av porcinreproduktive og andedrettssyndromvirus - Google Patents

N-proteinmutanter av porcinreproduktive og andedrettssyndromvirus

Info

Publication number
NO20074885L
NO20074885L NO20074885A NO20074885A NO20074885L NO 20074885 L NO20074885 L NO 20074885L NO 20074885 A NO20074885 A NO 20074885A NO 20074885 A NO20074885 A NO 20074885A NO 20074885 L NO20074885 L NO 20074885L
Authority
NO
Norway
Prior art keywords
respiratory syndrome
syndrome virus
porcine reproductive
protein mutants
virus
Prior art date
Application number
NO20074885A
Other languages
English (en)
Inventor
Dongwan Yoo
Changhee Lee
Jay Gregory Calvert
Siao-Kun Welch
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20074885L publication Critical patent/NO20074885L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10061—Methods of inactivation or attenuation
    • C12N2770/10062—Methods of inactivation or attenuation by genetic engineering

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Oppfinnelsen angår et genetisk modifisert PRRS-virus og polynukleotider som koder for dette. Vaksiner omfattende det genetisk modifiserte virus og polynukleotider er også frembrakt.
NO20074885A 2005-02-25 2007-09-25 N-proteinmutanter av porcinreproduktive og andedrettssyndromvirus NO20074885L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65652305P 2005-02-25 2005-02-25
US73066305P 2005-10-27 2005-10-27
PCT/IB2006/000376 WO2006129139A1 (en) 2005-02-25 2006-02-13 N protein mutants of porcine reproductive and respiratory syndrome virus

Publications (1)

Publication Number Publication Date
NO20074885L true NO20074885L (no) 2007-11-22

Family

ID=36218763

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074885A NO20074885L (no) 2005-02-25 2007-09-25 N-proteinmutanter av porcinreproduktive og andedrettssyndromvirus

Country Status (15)

Country Link
US (3) US7544362B1 (no)
EP (1) EP1856141A1 (no)
JP (1) JP4320357B2 (no)
KR (2) KR100996105B1 (no)
CN (1) CN101128478B (no)
AR (1) AR052392A1 (no)
AU (1) AU2006253891B2 (no)
BR (1) BRPI0606189A2 (no)
CA (1) CA2599322C (no)
MX (1) MX2007009060A (no)
NO (1) NO20074885L (no)
NZ (1) NZ561848A (no)
RU (1) RU2381035C2 (no)
TW (1) TWI366602B (no)
WO (1) WO2006129139A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006129139A1 (en) * 2005-02-25 2006-12-07 Pfizer Products Inc. N protein mutants of porcine reproductive and respiratory syndrome virus
JP2012505653A (ja) * 2008-10-16 2012-03-08 ファイザー・インク トルクテノウイルス（ＴｏｒｑｕｅＴｅｎｏＶｉｒｕｓｕ：ＴＴＶ）単離株および組成物
US8846388B2 (en) 2009-10-16 2014-09-30 Zoetis Llc Infectious clones of torque teno virus
UA108902C2 (uk) * 2010-11-10 2015-06-25 Вірус північноамериканського репродуктивного та респіраторного синдрому свиней (prrs) та його застосування
WO2012163258A1 (en) 2011-05-27 2012-12-06 Sinovet (Beijing) Biotechnology Co.,Ltd Combined vaccines for prevention of porcine virus infections
EP2718429A1 (en) 2011-06-08 2014-04-16 Zoetis LLC Infectious clones of torque teno virus
JP2014523878A (ja) * 2011-06-14 2014-09-18 グローブイミューン，インコーポレイテッド Ｄ型肝炎ウイルス感染の治療又は予防のための酵母ベースの組成物及び方法
WO2013163337A1 (en) * 2012-04-24 2013-10-31 The Ohio State University Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome
KR102012109B1 (ko) * 2012-05-17 2019-08-19 조에티스 엘엘씨 이유 전 돼지 생식기 호흡기 증후군(prrs) 바이러스에 대한 효과적인 백신접종
KR102276341B1 (ko) * 2020-01-29 2021-07-12 주식회사 바이오포아 유럽형 돼지 생식기 호흡기 증후군 바이러스의 제조 방법 및 이의 용도
KR102402645B1 (ko) * 2020-01-29 2022-05-26 주식회사 바이오포아 유럽형 돼지 생식기 호흡기 증후군 바이러스의 변이주 및 이를 포함하는 백신 조성물
WO2021154055A1 (ko) * 2020-01-29 2021-08-05 주식회사 바이오포아 유럽형 돼지 생식기 호흡기 증후군 바이러스의 변이주 및 이를 포함하는 백신 조성물
CN114315984B (zh) * 2021-12-29 2023-02-03 中国农业科学院兰州兽医研究所 一种用于制备prrsv基因ii型表位缺失疫苗毒株的n蛋白表位突变标记及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0839912A1 (en) * 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
NZ513289A (en) * 1998-12-22 2003-04-29 Pfizer Prod Inc Infectious cDNA clone of north american procine reproductive and respiratory syndrome (PRRS) virus and uses thereof
JP3961222B2 (ja) * 1999-03-08 2007-08-22 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー Ｐｒｒｓｖワクチン
WO2002095040A1 (en) * 2001-05-21 2002-11-28 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Delections in arterivirus replicons
AU2001228502A1 (en) * 2000-01-26 2001-08-07 Boehringer Ingelheim Vetmedica Gmbh Recombinant attenuation of prrsv
MXPA03007751A (es) * 2001-03-09 2004-11-12 Boehringer Ingelheim Vetmed Cepas vivas atenuadas del virus prrs.
WO2006129139A1 (en) * 2005-02-25 2006-12-07 Pfizer Products Inc. N protein mutants of porcine reproductive and respiratory syndrome virus

Also Published As

Publication number Publication date
CA2599322A1 (en) 2006-12-07
CN101128478A (zh) 2008-02-20
US20090130143A1 (en) 2009-05-21
KR20100090311A (ko) 2010-08-13
RU2007131536A (ru) 2009-03-27
WO2006129139A1 (en) 2006-12-07
CA2599322C (en) 2013-09-03
JP2008531006A (ja) 2008-08-14
AU2006253891A1 (en) 2006-12-07
KR100996105B1 (ko) 2010-11-22
EP1856141A1 (en) 2007-11-21
NZ561848A (en) 2010-02-26
RU2381035C2 (ru) 2010-02-10
US20090226486A1 (en) 2009-09-10
TW200641126A (en) 2006-12-01
BRPI0606189A2 (pt) 2009-06-09
AR052392A1 (es) 2007-03-14
TWI366602B (en) 2012-06-21
US8128937B2 (en) 2012-03-06
KR20070095453A (ko) 2007-09-28
MX2007009060A (es) 2007-09-11
JP4320357B2 (ja) 2009-08-26
US20100136051A1 (en) 2010-06-03
CN101128478B (zh) 2013-08-14
US7544362B1 (en) 2009-06-09
AU2006253891B2 (en) 2011-12-01

Similar Documents

Publication Publication Date Title
NO20074885L (no) N-proteinmutanter av porcinreproduktive og andedrettssyndromvirus
DK1951882T3 (da) Nukleinsyrer, der koder for vacciner mod porcint reproduktions- og respirationssyndromvirus (PRRSV)
LTC1971366I2 (lt) Žmogaus anti-IL-23 antikūnai, kompozicijos, metodai ir panaudojimai
BRPI0510674A (pt) variantes fc otimizadas
EP1794329A4 (en) ISOLATES OF PORCINE RESPIRATORY DYSGENESIS SYNDROME (SDRP), AND METHODS OF USE
NO20080246L (no) Anti-IGF1R-antistofformuleringer
ATE465176T1 (de) Il-7-varianten mit reduzierter immunogenität
NO20092052L (no) Antistoffer og immunkonjugater, og anvendelser derav
GB2438802A (en) Structure of the hepatitis C virus NS5A protein
EA200702643A1 (ru) Антитела, связывающие tweak
NO20083895L (no) Anti-IGF-1R human monoklonalantibody formulering
NO20084893L (no) Lyofiliserte terapeutiske peptistoffpreparater
NO20073065L (no) Injiserbare nanopartikulaere olanzapinformuleringer
BRPI0314814C1 (pt) anticorpo compreendendo uma variante de fc
NO20076687L (no) Oral doseringsform
DK1833508T3 (da) Virusstammer og sammensætninger af PRRS-syndromet (porcint reproduktivt og respiratorisk syndrom)
CL2008001258A1 (es) Kit de vacuna que comprende al menos nueve conjugados de sacaridos de antgenos hb o hib, donde al menos 2-7 son con la proteina transportadora crm, siendo dicho kit adecuado para usar en su calendario de inmunizacion primaria; vacuna combinada adecuada para la inmunizacion primaria.
NO20065115L (no) Cellulaer tillatende faktor for virus, og anvendelse derav
MX2007010220A (es) Peptidos para la deteccion de anticuerpo para el virus del sindrome respiratorio reproductivo porcino.
FI20055630A (fi) Kasvonaamio
UA97369C2 (ru) Противоопухолевые соединения дигидропиран-2-она и фармацевтическая композиция на их основе
DK1987357T3 (da) Polypeptider, som genkendes af anti-Trichinella-antistoffer, og anvendelser deraf
FR2876372B1 (fr) Composition generatrice de gaz.
MX2009003300A (es) Vectores de rhinovirus recombinantes.
NO20090395L (no) Farmasoytiske preparater inneholdende monoklonale antidiotype anti-CA-125-antistoff og aluminiumderivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application